— Research monograph
NAD+
The central redox coenzyme studied across cellular-energy and aging models.
Updated
- Class
- Pyridine nucleotide coenzyme — NOT a peptide
- Half-life (research)
- Variable by route; intracellular NAD+ pools are continuously cycled.
- Origin
- NAD was discovered by Arthur Harden and William John Young in 1906 during fermentation research. Sirtuin biology — a major focus of contemporary NAD+ research — emerged through the work of Leonard Guarente, David Sinclair, and others in the late 1990s and 2000s.
- Solubility
- Highly water-soluble. Physicochemical context only. Merit Sciences publishes no reconstitution or preparation procedures.
What is NAD+?
Nicotinamide Adenine Dinucleotide (NAD+) is a pyridine nucleotide coenzyme present in every living cell. It is not a peptide and does not fit the strict "research peptide" category — it is stocked because the cellular-pathway literature on NAD+ is deep, the reorder pattern is consistent, and many of the researchers buying Merit peptides also work with NAD+.
NAD+ functions both as a redox cofactor and as a substrate for an expanding family of NAD-consuming enzymes including the sirtuins (SIRT1-7), poly(ADP-ribose) polymerases (PARPs), and CD38.
How does NAD+ work?
Redox cofactor in catabolic and biosynthetic pathways (NAD+/NADH cycling). Substrate for sirtuin deacetylase activity. Substrate for PARP-mediated DNA damage signaling. Central to mitochondrial electron-transport-chain function.
Research applications
- Sirtuin biology research
- Mitochondrial bioenergetics
- PARP / DNA-damage-response signaling
- Cellular aging models
- Metabolic flux studies
NAD+ at Merit
Research review on The Assay, Merit’s editorial publication: MOTS-c vs NAD+: What the Published Research Compares
Form & storage
NAD+ ships as a sealed, lyophilized (freeze-dried) powder. Highly water-soluble. Physicochemical context only. Merit Sciences publishes no reconstitution or preparation procedures. Store sealed, light-protected, and follow your institution’s handling procedures for research materials.
Frequently asked questions
What is NAD+?
Nicotinamide Adenine Dinucleotide (NAD+) is a pyridine nucleotide coenzyme present in every living cell. It is not a peptide and does not fit the strict "research peptide" category — it is stocked because the cellular-pathway literature on NAD+ is deep, the reorder pattern is consistent, and many of the researchers buying Merit peptides also work with NAD+. Merit supplies it as a lyophilized research compound for research use only, not for human or veterinary use.
How does NAD+ work?
Redox cofactor in catabolic and biosynthetic pathways (NAD+/NADH cycling). Substrate for sirtuin deacetylase activity. Substrate for PARP-mediated DNA damage signaling. Central to mitochondrial electron-transport-chain function. Mechanistic descriptions summarize published preclinical findings and are not clinical claims.
What is the half-life of NAD+?
Variable by route; intracellular NAD+ pools are continuously cycled. Values reflect preclinical or research-context reports, not clinical pharmacokinetics.
Is Merit NAD+ for human use?
No. It is sold strictly for research use only: not for human or veterinary use, and not for diagnostic or therapeutic use.
Is NAD+ FDA-approved?
NAD+ is not approved by the FDA as a drug for any use. Supplied for research use only.
How is each batch of NAD+ tested?
Every Merit batch is tested by an independent laboratory for identity and HPLC purity before it is listed, and Merit identifies batches by date rather than by lot number. Current certificates: NAD+ 500 mg, July 2026 batch, 99.43% purity (meritsciences.com/coa/COA-2026-S0NBJY).
Regulatory status checked October 22, 2026 against: Drugs@FDA, FDA 503A categories list.
References
- NAD+ and sirtuins in aging and disease. Imai S, Guarente L. Trends in Cell Biology, 2014 · PMID 24786309
- NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Yoshino J, Baur JA, Imai S. Cell Metabolism, 2018 · PMID 29249689
- NAD+ in aging, metabolism, and neurodegeneration. Verdin E. Science, 2015 · PMID 26785480
- Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Rajman L, Chwalek K, Sinclair DA. Cell Metabolism, 2018 · PMID 29514064
For research use only. Not for human or veterinary use. Reference information summarized from published literature, not medical advice.
— Keep reading